Evotec Receives $6-Million Payment From Bristol-Myers Squibb to Expand Collaboration
January 07 2020 - 2:45AM
Dow Jones News
By Giulia Petroni
Evotec SE (EVT.XE) said Tuesday that it has received a
$6-million payment from Bristol-Myers Squibb Co. (BMY) following
the decision to include additional cell lines as part of a
collaboration over neurodegenerative diseases.
The German drug discovery and development company said the
partnership started in December 2016 to identify disease-modifying
treatments for a broad range of neurodegenerative diseases, and
that it has been expanded with additional cell lines multiple
times.
Write to Giulia Petroni at giulia.petroni@wsj.com
(END) Dow Jones Newswires
January 07, 2020 02:30 ET (07:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Sep 2023 to Sep 2024